Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: A multi-institutional registry

Journal of the American College of Surgeons

Volumn 213, Issue 4, 2011, Pages 493-500

  Martin II, Robert C G ^a   Rustein, Lisa ^c   Enguix, Daniel Pérez ^d   Palmero, Julio ^e   Carvalheiro, Victor ^f   Urbano, Jose ^g   Valdata, Alessandro ^h   Kralj, Ivan ⁱ   Bosnjakovic, Petar ⁱ   Tatum, Cliff ^b  

^a University of Louisville School of Medicine   (United States)

^b Norton Radiology   (United States)

^c MAINE MEDICAL CENTER   (United States)

^d Le Fe Hospital   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^h GALLIERA HOSPITAL   (Italy)

ⁱ Diakonissenkrankenhaus Karlsruhe Rüppur ^*  (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MICROSPHERE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER REGISTRY; CANCER SURVIVAL; DRUG EFFICACY; DRUG THERAPY; FEMALE; HEPATIC INTRA ARTERIAL THERAPY; HUMAN; HYPOTHESIS; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME;

EID: 81555211149     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2011.07.010     Document Type: Article

References (21)

1. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429-442. (Pubitemid 36152543)
2. Bruix J, Sherman M.Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236. (Pubitemid 43112690)
3. Nakamura H, Hashimoto T, Oi H, et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989;170:783-786. (Pubitemid 19062602)
4. Gee M, Soulen MC. Chemoembolization for hepatic metastases. Tech Vasc Interv Radiol 2002;5:132-140. (Pubitemid 36078169)
5. Lewis AL, Taylor RR, Hall B, et al. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 2006; 17:1335-1343. (Pubitemid 44259017)
6. Poon RT, Tso WK, Pang RW, et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intraarterial drug-eluting bead. Clin Gastroenterol Hepatol 2007;5: 1100-1108.
7. Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010;33:41-52.
8. Levine MN, Julian JA. Registries that show efficacy: good, but not good enough. J Clin Oncol 2008;26:5316-5319.
9. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.
10. Brown DB, Gould JE, Gervais DA, et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009;20:S425-S434.
11. Malagari K. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead. Expert Rev Anticancer Ther 2008;8:1643-1650.
12. Kettenbach J, Stadler A, Katzler IV, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol 2008;31:468-476.
13. Bilimoria MM, Lauwers GY,DohertyDAet al.Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001;136:528-535. (Pubitemid 32417542)
14. Lang BH, Poon RT, Fan ST, et al. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 2003;138: 1207-1213. (Pubitemid 37392394)
15. Verslype C, Van CE, Dicato M, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol 2009;20 (Suppl 7): vii1-vii6.
16. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-977.
17. Okamoto Y, Konno A, Togawa K, et al. Arterial chemoembolization with cisplatin microcapsules. Br J Cancer 1986;53:369-375. (Pubitemid 16133107)
18. Egawa H,Maki A,Mori K, et al. Effects of intra-arterial chemotherapy with a new lipophilic anticancer agent, estradiolchlorambucil (KM2210), dissolved in lipiodol on experimental liver tumor in rats. J Surg Oncol 1990;44:109-114. (Pubitemid 20200308)
19. Kruskal JB, Hlatky L, Hahnfeldt P et al. In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors. J Vasc Interv Radiol 1993;4:741-747.
20. Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007;46:474-481. (Pubitemid 46201723)
21. Reyes DK, Vossen JA, Kamel IR, et al. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 2009;15:526-532.